Skip to main content

Advertisement

SpringerLink
Log in

Practical guide to palliative sedation

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Terminally ill patients want assurance that their symptoms will be controlled as death approaches. Most patients can have a peaceful death with standard palliative care. Some patients approaching death, however, have refractory symptoms such as pain, dyspnea, nausea, and agitated delirium. Palliative sedation (PS), the use of medications to induce sedation in order to control refractory symptoms near death, is a therapeutic option for these patients. The reported frequency of PS use varies greatly, ranging from 5% to 52% of the terminally ill. One concern with PS is its effect on survival. Data suggest that PS does not lead to immediate death, with the median time to death after initiating PS being greater than 1 to 5 days. A number of medications have been used for PS, but midazolam is most commonly reported. PS is distinct from euthanasia because the intent of PS is relief from suffering without death as a required outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Singer PA, Martin DK, Kelner M: Quality end of life care: patients’ perspectives. JAMA 1999, 281:163–168.

    Article  PubMed  CAS  Google Scholar 

  2. Wein S: Sedation in the imminently dying patient. Oncology 2000, 14:585–590. This author emphasizes that sedative titration should be focused on clinical need and not on level of sedation and recommends that the physician be at the bedside to titrate medication until the patient’s symptoms are controlled. At that time, a maintenance dose should be prescribed.

    PubMed  CAS  Google Scholar 

  3. Seale CF: What happens in hospices: a review of research evidence. Soc Sci Med 1989, 28:551–559.

    Article  PubMed  CAS  Google Scholar 

  4. Wallston KA, Burger C, Smith RA, Baugher RJ: Comparing the quality of death for hospice and non-hospice cancer patients. Med Care 1988, 26:177–182.

    Article  PubMed  CAS  Google Scholar 

  5. Quill TE, Byock IR: Responding to intractable terminal suffering: the role of sedation and voluntary refusal of food and fluids. Ann Int Med 2000, 132:408–414.

    PubMed  CAS  Google Scholar 

  6. Fainsinger RL, Waller A, Bercovici M, et al.: A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000, 14:257–265. This study includes a diverse international population and characterizes the symptoms requiring palliative sedation, with delirium and dyspnea being most common. Midazolam is reported to be the most frequently used agent.

    Article  PubMed  CAS  Google Scholar 

  7. Adam J: ABC of palliative care: the last 48 hours. BMJ 1997, 315:1600–1603.

    PubMed  CAS  Google Scholar 

  8. Lichter I, Hunt E: The last 48 hours of life. J Palliat Care 1990, 6:7–15.

    PubMed  CAS  Google Scholar 

  9. Grond S, Zech D, Schug SA, et al.: Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symtom Manage 1991, 6:411–422.

    Article  CAS  Google Scholar 

  10. McKegney FP, Bailey LR, Yates JW: Prediction and management of pain patients with advanced cancer. Gen Hosp Psychiatry 1981, 3:95–101.

    Article  PubMed  CAS  Google Scholar 

  11. Ventafridda V, Ripamonte C, De Conno F, et al.: Symptom prevalence and control during cancer patients’ last days of life. J Palliat Care 1990, 6:7–11.

    PubMed  CAS  Google Scholar 

  12. Coyle N, Adelhardt J, Foley KM, Portenoy RK: Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 1990, 5:83–93.

    Article  PubMed  CAS  Google Scholar 

  13. Fainsinger R, Miller MJ, Bruera E, et al.: Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991, 7:5–11.

    Google Scholar 

  14. Voltz R, Borasio GD: Palliative therapy in the terminal stage of neurological disease. J Neurol 1997, 244(suppl 14):S2-S10.

    Article  PubMed  Google Scholar 

  15. Fainsinger RL, Tapper M, Bruera E: A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 1993, 9:4–8.

    PubMed  CAS  Google Scholar 

  16. Fainsinger RL, MacEachern T, Miller MJ, et al.: The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994, 9:298–302.

    Article  PubMed  CAS  Google Scholar 

  17. Breitbart W, Bruera E, Chochinov H, et al.: Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage 1995, 10:131–141.

    Article  PubMed  CAS  Google Scholar 

  18. Enck RE: Drug induced terminal sedation for symptom control. Am Hosp Palliat Care 1991, 8:3–5.

    Google Scholar 

  19. Greene WR, Davis WH: Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J 1991, 84:332–337.

    PubMed  CAS  Google Scholar 

  20. Back IN: Terminal restlessness in patients with advanced malignant disease. Palliat Med 1992, 6:293–298.

    Google Scholar 

  21. Billings JA, Block SD: Slow euthanasia. J Palliat Care 1996, 12:21–30.

    PubMed  CAS  Google Scholar 

  22. Burke AL, Diamond PL, Hulbert J, et al.: Terminal restlessness: its management and the role of midazolam. Med J Aust 1991, 155:485–487.

    PubMed  CAS  Google Scholar 

  23. Chater S, Viola R, Paterson J, Jarvis V: Sedation for intractable distress in the dying: a survey of experts. Palliat Med 1998, 12:255–269.

    Article  PubMed  CAS  Google Scholar 

  24. Cherny NI, Portenoy RK: Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994, 10:31–38.

    PubMed  CAS  Google Scholar 

  25. Fainsinger RL: Use of sedation by a hospital palliative care support team. J Palliat Care 1998, 14:51–54.

    PubMed  CAS  Google Scholar 

  26. McIver B, Walsh D, Nelson K: The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994, 9:341–345.

    Article  PubMed  CAS  Google Scholar 

  27. Mercadante S, De Conno F, Ripamonti C: Propofol in terminal care. J Pain Symptom Manage 1995, 10:639–642.

    Article  PubMed  CAS  Google Scholar 

  28. Morita T, Inoue S, Chihara S: Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996, 12:32–38.

    Article  PubMed  CAS  Google Scholar 

  29. Portenoy RK: Morphine infusions at the end of life: the pitfalls in reasoning from anecdote. J Palliat Care 1996, 12:44–46.

    PubMed  CAS  Google Scholar 

  30. Stone P, Phillips C, Spruyt O, Waight C: A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997, 11:140–144.

    PubMed  CAS  Google Scholar 

  31. Storey P: Symptom control in dying. In Principles and Practice of Supportive Care. Edited by Berger AM, Portenoy RK, Weissman DE. Philadelphia: Lippincott-Raven; 1998:741–748.

    Google Scholar 

  32. Loewy EH: Terminal sedation, self-starvation, and orchestrating the end of life. Arch Intern Med 2001, 161:329–332.

    Article  PubMed  CAS  Google Scholar 

  33. Rousseau P: The ethical validity and clinical experience of palliative sedation. Mayo Clin Proc 2000, 75:1064–1069. This article provides a thorough literature review of palliative sedation and discusses the importance of the principle of double effect.

    PubMed  CAS  Google Scholar 

  34. Hardy J: Sedation in terminally ill patients. Lancet 2000, 356:1866–1867.

    Article  PubMed  CAS  Google Scholar 

  35. Krakauer EL, Penson RT, Troug RD, et al.: Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist 2000, 5:53–62.

    Article  PubMed  CAS  Google Scholar 

  36. Morita T, Tsunoda J, Inoue S, Chihara S: Do hospice clinicians sedate patients intending to hasten death? J Palliat Care 1999, 15:20–23.

    PubMed  CAS  Google Scholar 

  37. Hallenbeck J: Terminal sedation for intractable distress. WMJ 1999, 171:222–223.

    CAS  Google Scholar 

  38. Rousseau P: Existential suffering and palliative sedation: a brief commentary with a proposal for clinical guidelines. Am J Hosp Palliat Care 2001, 18:151–153.

    Article  PubMed  CAS  Google Scholar 

  39. Gauthier CC: Active voluntary euthanasia, terminal sedation, and assisted suicide. J Clin Ethics 2001, 12:43–49. The author discusses specific legislation and public policy relating to palliative sedation as well as active voluntary euthanasia and physician-assisted suicide.

    PubMed  CAS  Google Scholar 

  40. Hallenbeck JL: Terminal sedation: ethical implications in different situations. J Palliat Med 2000, 3:313–319.

    Article  PubMed  CAS  Google Scholar 

  41. Fainsinger RL, Landman W, Hoskings M, Bruera E: Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998, 16:145–52.

    Article  PubMed  CAS  Google Scholar 

  42. Cowan JD, Walsh D: Terminal sedation in palliative medicine: definition and review of the literature. Support Care Cancer 2001, 9:403–407. The authors review and analyze 27 studies involving terminal sedation and provide specific information concerning medication dosage, route of administration, and efficacy.

    Article  PubMed  CAS  Google Scholar 

  43. Chiu T-Y, Hu W-Y, Lue B-H, et al.: Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001, 21:467–472.

    Article  PubMed  CAS  Google Scholar 

  44. Cherny NI: The use of sedation in the management of refractory pain. Prin Pract Support Oncol Updates 2000, 3:1–11. This article describes specific therapies that should be tried or considered before pain is labeled refractory.

    Google Scholar 

  45. Fainsinger RL, De Moissac D, Mancini I, Oneschuk D: Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000, 16:5–10.

    PubMed  CAS  Google Scholar 

  46. Truog RD, Berde CB, Mitchell C, et al.: Barbiturates in the care of the terminally ill. N Engl J Med 1992, 327:1678–1682.

    Article  PubMed  CAS  Google Scholar 

  47. Cherny NI, Coyle N, Foley KM: The treatment of suffering when patients request elective death. J Palliat Care 1994, 10:71–79.

    PubMed  CAS  Google Scholar 

  48. Mount B: Morphine drips, terminal sedation, and slow euthanasia: definitions and facts, not anecdotes. J Palliat Care 1996, 12:31–37.

    PubMed  CAS  Google Scholar 

  49. Lo B: Improving care near the end of life: why is it so hard? JAMA 1995, 274:1634–1636.

    Article  PubMed  CAS  Google Scholar 

  50. den Daas N: Estimating length of survival in end stage cancer: a review of the literature. J Pain Symptom Manage 1995, 10:548–555.

    Article  Google Scholar 

  51. Morita T, Tsunoda J, Inoue S, Chihara S: Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 2001, 21:282–289. This study analyzes previously collected data on 209 hospice patients and examines the effect of opioids and sedatives on patients in their last 48 hours of life. The authors conclude that opioids and sedatives do not have an impact on survival in terminally ill patients.

    Article  PubMed  CAS  Google Scholar 

  52. Storey P, Hill HH, St Louis RH, Tarver EE: Subcutaneous infusions for control of cancer symptoms. J Pain Symptom Manage 1990, 5:33–41.

    Article  PubMed  CAS  Google Scholar 

  53. McNamara P, Minton M, Twycross RG: Use of midazolam in palliative care. Palliat Med 1991, 5:244–249.

    Google Scholar 

  54. Waller A, Caroline NL: Handbook of Palliative Care. Boston: Buterworth-Heinemann; 1996.

    Google Scholar 

  55. Bottomley DM, Hanks GW: Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 1990, 5:259–261.

    Article  PubMed  CAS  Google Scholar 

  56. Glover ML, Kodish E, Reed MD: Continuous propofol infusion for the relief of treatment-resistant discomfort in a terminally ill pediatric patient with cancer. J Pediatr Hematol Oncol 1996, 18:377–380.

    Article  PubMed  CAS  Google Scholar 

  57. Moyle J: The use of propofol in palliative medicine. J Pain Symptom Manage 1995, 10:643–646.

    Article  PubMed  CAS  Google Scholar 

  58. Orentlicher D: The Supreme Court and physician-assisted suicide: rejecting assisted suicide but embracing euthanasia. N Engl J Med 1997, 337:1236–1239.

    Article  PubMed  CAS  Google Scholar 

  59. New Catholic Encyclopedia, vol 4. New York: McGraw-Hill; 1967 4:1020-1022.

  60. Quill TE, Dresser R, Brock DW: The rule of double effect: a critique of its role in end-of-life decision making. N Engl J Med 1997, 337:1768–1771.

    Article  PubMed  CAS  Google Scholar 

  61. Craig GM: On withholding artificial hydration and nutrition from terminally ill sedated patients: the debate continues. J Med Ethics 1996, 22:147–153.

    Article  PubMed  CAS  Google Scholar 

  62. Craig GM: On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? J Med Ethics 1994, 20:139–143.

    PubMed  CAS  Google Scholar 

  63. Craig G: Is sedation without hydration or nourishment in terminal care lawful? Med Leg J 1994, 62:198–201.

    Google Scholar 

  64. Brody H: Causing, intending, and assisting death. J Clin Ethics 1993, 4:112–117.

    PubMed  CAS  Google Scholar 

  65. Quill TE: The ambiguity of clinical intentions. N Engl J Med 1993, 329:1039–1040.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advanced Illness Assistance Team, Blount Memorial Hospital, 907 East Lamar Alexander Parkway, 37804, Maryville, TN, USA

    John D. Cowan MD & Teresa W. Palmer RN, MSN

Authors
  1. John D. Cowan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa W. Palmer RN, MSN
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cowan, J.D., Palmer, T.W. Practical guide to palliative sedation. Curr Oncol Rep 4, 242–249 (2002). https://doi.org/10.1007/s11912-002-0022-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-002-0022-2

Keywords

Search

Navigation